Ardelyx Inc. ARDX
Super Investor & Insider
Nessuna transazione insider negli ultimi 6 mesi.
Fondi: 13F-HR alla SEC. Insider: acquisti (P) e vendite (S) in borsa da SEC EDGAR, ultimi 12 mesi.
About
Ardelyx Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing first-in-class medicines to address unmet medical needs in gastrointestinal and cardio-renal diseases. The company employs an innovative platform that identifies new biological mechanisms and pathways, enabling the creat…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees395
TickerARDX
Statistics
Market Cap$1.43B
Revenue (TTM)$407.3M
Net Income-$61.6M
Net Margin-15.1%
EPS$-0.26
P/E-22.38
P/S3.24
P/B9.32
EV/EBITDA-40.51
ROE-39.5%
Dividend Yield—
Price$5.79
Data: Twelve Data · Revenue = mcap / P/S